|
ADNP2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62481139653892E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.43693953905222E-13 |
| Normal-vs-Stage2 |
4.11589999971262E-07 |
| Normal-vs-Stage3 |
9.06209551843062E-11 |
| Normal-vs-Stage4 |
1.49420031902991E-10 |
| Stage1-vs-Stage2 |
8.828800E-01 |
| Stage1-vs-Stage3 |
2.662200E-01 |
| Stage1-vs-Stage4 |
1.541830E-01 |
| Stage2-vs-Stage3 |
3.618800E-01 |
| Stage2-vs-Stage4 |
2.659800E-01 |
| Stage3-vs-Stage4 |
6.981400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.88578058618805E-15 |
| Normal-vs-AfricanAmerican |
6.421700E-04 |
| Normal-vs-Asian |
2.96930002807727E-09 |
| Caucasian-vs-AfricanAmerican |
2.163000E-01 |
| Caucasian-vs-Asian |
6.293400E-01 |
| AfricanAmerican-vs-Asian |
1.456420E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.0584000342817E-10 |
| Normal-vs-Female |
1.63147273468667E-12 |
| Male-vs-Female |
3.571000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.6714962747244E-11 |
| Normal-vs-Age(41-60Yrs) |
2.08721928629529E-14 |
| Normal-vs-Age(61-80Yrs) |
6.02479954814328E-10 |
| Normal-vs-Age(81-100Yrs) |
1.591670E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.006000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.995200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.347400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.515400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.548600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.221000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.612300E-02 |
| Classical-VS-Follicular |
9.590000E-02 |
| Classical-VS-Other |
1.682160E-01 |
| Classical-VS-Normal |
1.12350000414096E-08 |
| Tall-VS-Follicular |
3.236000E-01 |
| Tall-VS-Other |
7.154800E-01 |
| Tall-VS-Normal |
2.29560037645626E-10 |
| Follicular-VS-Other |
4.813800E-01 |
| Follicular-VS-Normal |
2.24430030115741E-10 |
| Other-VS-Normal |
6.351900E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.9960036108132E-15 |
| Normal-vs-N1 |
6.49279519038259E-11 |
| N0-vs-N1 |
2.773800E-01 |
|
|
